BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03580356-completion@plaintrial.com
DTSTAMP:20261027T192721Z
DTSTART;VALUE=DATE:20220614
SUMMARY:A Phase III Study of and Efficacy of Ligelizumab in the Treatment o
 f CSU in Adolescents and Adults Inadequately Controlled With H1-antihistam
 ines. — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03580356
URL:https://plaintrial.com/trial/NCT03580356
END:VEVENT
END:VCALENDAR